Avirmax Inc., a company focused on delivering protein therapeutics via recombinant adeno-associated viral (rAAV) vectors announced that the United States Patent and Trademark Office...
Ascletis Pharma Inc. announces dosing of 24 healthy subjects of the first 3 cohorts in multiple-dose escalation Phase I clinical trial of oral RNA-dependent...
Mission Bio, the pioneer in single-cell DNA and multi-omics analysis, announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay...
BioLink Life Sciences of Cary, North Carolina, today announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the...
